Expression of perlecan, syndecan-1 and Ki-67 in keratocystic odontogenic tumor

Taylor, 2008, New findings and controversies in odontogenic tumors, Med Oral Pathol Oral Cir Bucal, 9, 555 Agaram, 2004, Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic, Arch Pathol Lab Med, 128, 313, 10.5858/2004-128-313-MATDTO Barreto, 2000, PTCH gene mutations in odontogenic keratocysts, J Dent Res, 79, 1418, 10.1177/00220345000790061101 Barnes, 2005, WHO classification of tumours series Maurette, 2006, Conservative treatment protocol of odontogenic keratocyst: a preliminary study, J Oral Maxillofac Surg, 64, 379, 10.1016/j.joms.2005.11.007 Chirapathomsakul, 2006, A review of odontogenic keratocysts and the behavior of recurrences, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101, 5, 10.1016/j.tripleo.2005.03.023 Browne, 1970, The odontogenic keratocyst: clinical aspects, Braz Dent J, 128, 225, 10.1038/sj.bdj.4802449 Neville, 2002, vol. 3, 589 Brannon, 1976, The odontogenic keratocyst. A clinicopathologic study of 312 cases. Part I. Clinical features, Oral Surg Oral Med Oral Pathol, 42, 54, 10.1016/0030-4220(76)90031-1 Brannon, 1977, The odontogenic keratocyst. A clinicopathologic study of 312 cases. Part II. Histological features, Oral Surg Oral Med Oral Pathol, 43, 233, 10.1016/0030-4220(77)90161-X Dominguez, 1988, Comparative study of keratocysts, associated and non-associated with nevoid basal cell carcinoma syndrome, J Oral Pathol, 17, 39, 10.1111/j.1600-0714.1988.tb01503.x Woolgar, 1987, A comparative study of the clinical and histological features of recurrent and non-recurrent odontogenic keratocysts, J Oral Pathol, 16, 124, 10.1111/j.1600-0714.1987.tb01478.x Blanas, 2000, Systemic review of the treatment and prognosis of the odontogenic keratocyst, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 90, 553, 10.1067/moe.2000.110814 Madras, 2008, Keratocystic odontogenic tumour: reclassification of the odontogenic keratocyst from cyst to tumour, JCDA, 74, 165 Farach-Carson, 2007, Perlecan-a multifunctional extracellular proteoglycan scaffold, Glycobiology, 17, 897, 10.1093/glycob/cwm043 Farach-Carson, 2005, Heparan sulfate proteoglycans: key players in cartilage biology, Crit Rev Eukaryot Gene Expr, 15, 29, 10.1615/CritRevEukaryotGeneExpr.v15.i1.30 Schofield, 1999, Expression of proteoglycan core proteins in human bone marrow stroma, Biochem J, 343, 663, 10.1042/0264-6021:3430663 Mohan, 1991, Characterization of heparan sulfate proteoglycan from calf lens capsule and proteoglycans synthesized by cultured lens epithelial cells: comparison with other basement membrane proteoglycans, J Biol Chem, 266, 8567, 10.1016/S0021-9258(18)93012-7 Tapanadechopone, 2001, Epidermal transformation leads to increased perlecan synthesis with heparin-binding growth factor affinity, Biochem J, 355, 517, 10.1042/0264-6021:3550517 Knox, 2002, Not all perlecans are created equal. Interactions with fibroblast growth factor (FGF) 2 and FGF receptors, J Biol Chem, 277, 14657, 10.1074/jbc.M111826200 Tufvesson, 2000, Alteration of proteoglycan synthesis in human lung fibroblasts induced by interleukin-1beta and tumor necrosis factor-alpha, J Cell Biochem, 7l7, 298, 10.1002/(SICI)1097-4644(20000501)77:2<298::AID-JCB12>3.0.CO;2-D Cattaruzza, 2005, Proteoglycan control of cell movement during wound healing and cancer spreading, Matrix Biol, 24, 400, 10.1016/j.matbio.2005.06.005 Lesot, 2002, 2 cell-cell and cell-matrix interactions during initial enamel organ histomorphogenesis in the mouse, Connect Tissue Res, 43, 191, 10.1080/03008200290000529 Ida-Yonemochi, 2005, Perlecan, a basement membrane type heparin sulfate proteoglycan, in the enamel organ: its intraepithelial localization in the stellate reticulum, J Histochem Cytochem, 53, 763, 10.1369/jhc.4A6479.2005 Ida-Yonemochi, 2006, Perlecan, a heparan sulfate proteoglycan, is a major constituent of the intraepithelial stroma functioning in tooth morphogeneis, J Oral Biosci, 48, 233, 10.1016/S1349-0079(06)80006-X Yamazaki, 2004, Basement membrane-type heparin sulfate proteoglycan (perlecan) and low-density lipoprotein(LDL) are co-localized in granulation tissues: a possible pathogenesis of cholesterol granulomas in jaw cysts, J Oral Pathol Med, 33, 177, 10.1111/j.0904-2512.2004.00087.x Ikarashi, 2004, Intraepithelial expression of perlecan, a basement membrane type heparan sulfate proteoglycan, reflects dysplastic changes of the oral mucosal epithelium, J Oral Pathol Med, 33, 71, 10.1111/j.1600-0714.2004.00026.x Elenius, 1991, Induced expression of syndecan in healing wounds, J Cell Biol, 114, 585, 10.1083/jcb.114.3.585 Bernfield, 1992, Biology of the syndecans, a family of transmembrane heparan sulfate proteoglycans, Annu Rev Cell Biol, 8, 365, 10.1146/annurev.cb.08.110192.002053 Carey, 1997, Syndecans: multifunctional cell-surface co-receptors, Biochem J, 327, 1, 10.1042/bj3270001 Liu, 1998, Heparan sulfate proteoglycans as adhesive and anti-invasive molecules, J Biol Chem, 273, 22825, 10.1074/jbc.273.35.22825 Hayashida, 2006, Syndecan-1 expression in epithelial cells is induced by transforming growth factor through a PKA-dependent pathway, J Biol Chem, 281, 24365, 10.1074/jbc.M509320200 Van Diest, 1998, Proliferation markers in tumors: interpretation and clinical value, J Clin Pathol, 51, 716, 10.1136/jcp.51.10.716 Tubiana, 1989, Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long term survival, Radiother Oncol, 15, 1, 10.1016/0167-8140(89)90113-8 Jacob, 1996, Heterogeneity of squamous cell carcinomas of the head and neck-analysis of tumor biologic factors and proliferation rates, Laryngoscope, 106, 1170, 10.1097/00005537-199609000-00023 Gerdes, 1984, Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67, J Immunol, 133, 1710, 10.4049/jimmunol.133.4.1710 Bruno, 1992, Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells, Cell Prolif, 25, 31, 10.1111/j.1365-2184.1992.tb01435.x Gerdes, 1990, Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluation in human malignancies, Semin Cancer Biol, 1, 199 Cattoretti, 1992, Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections, J Pathol, 168, 357, 10.1002/path.1711680404 Iozzo, 2005, Basement membrane proteoglycans: from cellar to ceiling, Nat Rev Mol Cell Biol, 6, 646, 10.1038/nrm1702 Tsuneki, 2008, Perlecan-rich epithelial linings as a background of proliferative potentials of keratocystic odontogenic tumor, J Oral Pathol Med, 37, 287, 10.1111/j.1600-0714.2007.00620.x Parish, 2006, The role of heparan sulphate in inflammation, Nat Rev Immunol, 6, 633, 10.1038/nri1918 Knox, 2006, Perlecan: how does one molecule do so many things?, Cell Mol Life Sci, 63, 2435, 10.1007/s00018-006-6162-z Regina, 2011, Syndecan-1 (CD138) and Ki-67 expression in odontogenic cystic lesions, Braz Dent J, 22, 223, 10.1590/S0103-64402011000300008 Kimi, 2000, Analysis of apoptosis-related factors and apoptotic cells in lining epithelium of odontogenic keratocysts, Oral Med Pathol, 5, 35, 10.3353/omp.5.35 Shear, 2002, The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 3. Immuno-cytochemistry of cytokeratin and other epithelial cell markers, Oral Oncol, 38, 407, 10.1016/S1368-8375(01)00067-7 Kimi, 2001, Immunohistochemical analysis of cell-cycle- and apoptosis-related factors in lining epithelium of odontogenic keratocysts, J Oral Pathol Med, 30, 434, 10.1034/j.1600-0714.2001.300709.x Kim, 2003, Comparative Ki-67 expression and apoptosis in the odontogenic keratocyst associated with or without an impacted tooth in addition to unilocular and multilocular varieties, Yonsei Med J, 44, 841, 10.3349/ymj.2003.44.5.841 Thosaporn, 2004, A comparative study of epithelial cell proliferation between the odontogenic keratocyst, orthokeratinized odontogenic cyst, dentigerous cyst, and ameloblastoma, Oral Dis, 10, 22, 10.1046/j.1354-523X.2003.00974.x Kichi, 2005, Cell proliferation, apoptosis and apoptosis-related factors in odontogenic keratocysts and in dentigerous cysts, J Oral Pathol Med, 34, 280, 10.1111/j.1600-0714.2005.00314.x Mendes, 2010, Biological pathways involved in the aggressive behavior of the keratocystic odontogenic tumor and possible implications for molecular oriented treatment – an overview, Oral Oncol, 46, 19, 10.1016/j.oraloncology.2009.10.009 Gadbail, 2011, Tumor angiogenesis in keratocystic odontogenic tumor assessed by using CD-105 antigen, J Oral Pathol Med, 40, 263, 10.1111/j.1600-0714.2010.00962.x Lo Muzio, 1999, Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome, J Dent Res, 78, 1345, 10.1177/00220345990780070901 Nadalin, 2011, Syndecan-1 (CD138) and Ki-67 expression in odontogenic cystic lesions, Braz Dent J, 22, 223, 10.1590/S0103-64402011000300008 Shear, 2002, The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2. Proliferation and genetic studies, Oral Oncol, 38, 323, 10.1016/S1368-8375(01)00066-5 Clarissa, 2008, Expression of Ki-67, p53 and p63 proteins in keratocyst odontogenic tumours: an immunohistochemical study, J Mol Hist, 39, 311, 10.1007/s10735-008-9167-0